Discordance between dipyridamole stress technetium-99m tetrofosmin single photon emission computed tomography and coronary angiography in patients with Kawasaki disease

CMUR > China Medical University Hospital > Jurnal articles > Item 310903500/29600

Please use this identifier to cite or link to this item: http://ir.cmu.edu.tw/ir/handle/310903500/29600

Title:	Discordance between dipyridamole stress technetium-99m tetrofosmin single photon emission computed tomography and coronary angiography in patients with Kawasaki disease
Authors:	Fu, YC;Shiau, YC;Tsai, SC;Kao, A;Hwang, BT;Chi, CS
Contributors:	附設醫院核子醫學部;China Med Coll Hosp, Dept Nucl Med, Taichung 404, Taiwan;China Med Coll Hosp, Dept Med Res, Taichung 404, Taiwan;Taichung Vet Gen Hosp, Dept Pediat, Taichung, Taiwan;Taipei Vet Gen Hosp, Dept Pediat, Taipei, Taiwan;Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan;Natl Taiwan Univ, Dept Nucl Med, Far Eastern Mem Hosp, Coll Elect Engn, Taipei 10764, Taiwan;Natl Taiwan Univ, Inst Biomed Engn, Coll Elect Engn, Taipei 10764, Taiwan;Show Chwan Mem Hosp, Dept Nucl Med, Changhua, Taiwan
Date:	2002
Issue Date:	2010-09-24 14:38:38 (UTC+8)
Publisher:	KLUWER ACADEMIC PUBL
Abstract:	The purpose of this study was investigate the role of 18F-2deoxyglucose positron emission tomography (FDG-PET) in staging small cell lung cancer (SCLC), its efficacy for the discrimination of limited disease (LD) and extensive disease (ED) stages and its regional sensitivity for different metastatic locations. Twenty-five patients with histologically confirmed SCLC and 42 radiologically-staged tumor sites were retrospectively investigated. The LD sample included 10 patients while the ED included 15 patients. All of the 25 primary tumor sites (100%) were visualized and 41 out of 42 (97.6%) of the metastases could be identified, but FDG-PET was needed for anatomical localization. The efficacy of FDG-PET was studied in the staging of SCLC patients and compared with the initial staging of conventional modality findings. FDG-PET down-staged (from ED to LD) one case and up-staged (from LD to ED) one case of SCLC. In summary, all of the patients with ED were correctly staged by FDG-PET alone. We conclude that FDG-PET is a substantial tool in the staging work-up of SCLC if it is performed initially to allow fast identification of patients with extensive disease stages and thus saves additional radiological or invasive examinations. Our preliminary results support the usefulness of whole body FDG-PET for staging SCLC.
Relation:	INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING 18(5):357-362
Appears in Collections:	[China Medical University Hospital] Jurnal articles

Files in This Item:

There are no files associated with this item.

Loading...